Vext Science ( (VEXTF) ) has released its Q3 earnings. Here is a breakdown of the information Vext Science presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vext Science, Inc. is a U.S.-based cannabis operator with operations in Arizona and Ohio, known for its vertical integration from cultivation to retail and its Vapen™ brand of THC products.
In its latest earnings report, Vext Science announced a significant 41% increase in revenue year-over-year for the third quarter of 2025, reaching $12.7 million. The company also reported a year-to-date operating cash flow of $8.5 million, showcasing strong financial performance driven by its expanding retail operations in Ohio and steady performance in Arizona.
Key financial highlights include a notable improvement in operating cash flow compared to the previous year and the strengthening of its retail presence in Ohio, where it aims to reach the state dispensary license cap by 2026. Despite mixed market dynamics, Vext’s operational discipline has allowed it to outperform state averages in Arizona and maintain a robust cash flow margin.
Looking ahead, Vext Science remains focused on maximizing performance across its Ohio dispensaries and advancing the construction and licensing of additional locations. The company is poised to leverage its vertically-integrated platform to drive sustainable growth and create long-term value for shareholders, according to its management’s outlook.